ALPMF OTC
Astellas Pharma Inc.
1W: -4.1%
1M: -3.0%
3M: -1.6%
YTD: +9.1%
1Y: +29.5%
3Y: +12.3%
5Y: -2.9%
$14.37
-0.30 (-2.06%)
Weekly Expected Move ±11.1%
$11
$13
$14
$16
$18
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$2,151B
Revenue
+12.5% YoY
$293B
Net Income
+477.5% YoY
$512B
Free Cash Flow
+225.0% YoY
75.9%
Gross Margin
14.5%
Op. Margin
8.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE17.5%
ROA8.5%
ROIC14.8%
Valuation
P/E11.0
P/B2.1
EV/EBITDA0.0
Leverage
Debt/Equity0.31
Current Ratio1.17
Interest Cov.34.3x
Quality Scores
Piotroski F8/9
Altman Z—
Beneish M-2.53